Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)
NCT00077844
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
3532
Enrollment
INDUSTRY
Sponsor class
Conditions
Percutaneous Coronary Intervention
Interventions
DRUG:
Enoxaparin sodium
Sponsor
Sanofi